The Cell & Gene Talent Crunch: Attracting Top-Notch Employees In A Competitive Landscape

By Cytiva

Talent and training programs can make a big difference in a molecule’s progress to commercialization, yet in the biopharmaceutical industry, talent is in short supply.

For emerging biopharma companies which may lack reach and resources, understanding how to develop, attract, and retain an advanced therapy, development, manufacturing, and clinical workforce is especially critical.

Michael Mehler, the senior clinical development manager for cell therapy oncology at GlaxoSmithKline, one of the largest pharmaceutical companies in the world, has observed over time how even one small batch with an error can negatively affect patients and cost a company its reputation and millions of dollars.

Mehler shares what it takes to identify and draw a trained workforce to your doorstep for both small and large pharmaceutical organizations.